References
- Bukowski, K.; Kciuk, M.; Kontek, R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci. 2020, 21, 3233. DOI: 10.3390/ijms21093233.
- Khazir, J.; Mir, B. A.; Pandita, M.; Pilcher, L.; Riley, D.; Chashoo, G. Design and Synthesis of Sulphonyl Acetamide Analogues of Quinazoline as Anticancer Agents. Med. Chem. Res. 2020, 29, 916–925. DOI: 10.1007/s00044-020-02533-4.
- Prenzel, N.; Fischer, O. M.; Streit, S.; Hart, S.; Ullrich, A. The Epidermal Growth Factor Receptor Family as a Central Element for Cellular Signal Transduction and Diversification. Endocr. Relat. Cancer 2001, 8, 11–31. DOI: 10.1677/erc.0.0080011.
- Ahmad, I. An Insight into the Therapeutic Potential of Quinazoline Derivatives as Anticancer Agents. Med. Chem. Commun. 2017, 8, 871–885. DOI: 10.1039/c7md00097a.
- Riham, F.,G.; Manal, K.; El-Ansary, D. Y.; El Kerdawy, A. M. Some 1,3,5-Trisubstituted Pyrazoline Derivatives Targeting Breast Cancer: Design, Synthesis, Cytotoxic Activity, EGFR Inhibition and Molecular Docking. Bioorg. Chem. 2020, 99, 103780. DOI: 10.1016/j.bioorg.2020.103780.
- Ramu, G. Bioorg. Med. Chem. Lett. 2017, 27, 4741–4748. DOI: 10.1016/j.bmcl.2017.08.064.
- Malinowski, Z.; Fornal, E.; Nowak, M.; Kontek, R.; Gajek, G.; Borek, B. Synthesis and Biological Evaluation of Some Amino- and Sulfanyl-3H-Quinazolin-4-One Derivatives as Potential Anticancer Agents. Monatsh. Chem. 2015, 146, 1723–1731. DOI: 10.1007/s00706-015-1508-6.
- Ioannis, K. K.; Abdelhakim, E.; Elisabeth, S.; Mauro, I.; Thierry, B. Tetrahedron Lett. 2007, 48, 6609–6613. DOI: 10.1016/j.tetlet.2007.07.114.
- Kshirsagar, U. A.; Mhaske, S. B.; Argade, N. P. Hexamethyldisilazane-Iodine Induced Intramolecular Dehydrative Cyclization of Diamides: A General Access to Natural and Unnatural Quinazolinones. Tetrahedron Lett. 2007, 48, 3243–3246. DOI: 10.1016/j.tetlet.2007.03.032.
- Aggarwal, S.; Sinha, D.; Tiwari, A. K.; Pooja, P.; Kaul, A.; Singh, G.; Mishra, A. K. Studies for Development of Novel Quinazolinones: New Biomarker for EGFR. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2015, 143, 309–318. DOI: 10.1016/j.saa.2015.01.069.
- Patel, H. M.; Pawara, R.; Ansari, A.; Noolvi, M.; Surana, S. Design and Synthesis of Quinazolinones as EGFR Inhibitors to Overcome EGFR Resistance Obstacle. Bioorg. Med. Chem. 2017, 25, 2713–2723. DOI: 10.1016/j.bmc.2017.03.039.
- Aziz, M. W.; Kamal, A. M.; Mohamed, K. O.; Elgendy, A. A. Design, Synthesis and Assessment of New Series of Quinazolinone Derivatives as EGFR Inhibitors along with Their Cytotoxic Evaluation against MCF7 and A549 Cancer Cell Lines. Bioorg. Med. Chem. Lett. 2021, 41, 127987. DOI: 10.1016/j.bmcl.2021.127987.
- Bogert, M. T.; Gortner, R. A.; Amend, C. G. Researches on Quinazolines (Twenty-Seventh Paper). the Synthesis of 3-Aminoaryl-4-Quinazolones from Acylanthranils and Aromatic Diamines. J. Am. Chem. Soc. 1911, 33, 949–962. DOI: 10.1021/ja02219a016.
- Hatem, M. G.; Mark, C. B.; Zeinab, A. M.; Sobhi, M. G. RSC Adv. 2017, 7, 14562–14610. DOI: 10.1039/C7RA00683G.